How to buy Forte Biosciences stock | $2.7

Forte Biosciences Inc is a biotechnology business based in the US. Forte Biosciences shares (FBRX) are listed on the NASDAQ and all prices are listed in US Dollars. Forte Biosciences employs 10 staff and has a market cap (total outstanding shares value) of 0.00.

Forte Biosciences stock price (NASDAQ: FBRX)

Use our graph to track the performance of FBRX stocks over time.

Forte Biosciences shares at a glance

• Key figures

Information last updated 2021-10-17.

Latest market close	$2.70
52-week range	$2.64 - $43.57
50-day moving average	$6.40
200-day moving average	$27.01
Wall St. target price	$3.25
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-1.61

Buy Forte Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Forte Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Forte Biosciences price performance over time

Historical closes compared with the close of $2.7 from 2021-10-18

1 week (2021-10-13)	-9.09%
1 month (2021-09-20)	-19.64%
3 months (2021-07-20)	-91.81%
6 months (2021-04-20)	-91.87%

1 year (2020-10-20)	-92.23%
2 years (2019-10-18)	357.39%
3 years (2018-10-19)	11.83
5 years (2016-10-16)	N/A

Forte Biosciences financials

Gross profit TTM	$0
Return on assets TTM	-30.77%
Return on equity TTM	-54.27%
Profit margin	0%
Book value	$3.55
Market capitalisation	$39.1 million

TTM: trailing 12 months

Shorting Forte Biosciences shares

There are currently 1.5 million Forte Biosciences shares held short by investors – that's known as Forte Biosciences's "short interest". This figure is 46.8% down from 2.7 million last month.

There are a few different ways that this level of interest in shorting Forte Biosciences shares can be evaluated.

Forte Biosciences's "short interest ratio" (SIR)

Forte Biosciences's "short interest ratio" (SIR) is the quantity of Forte Biosciences shares currently shorted divided by the average quantity of Forte Biosciences shares traded daily (recently around 5.4 million). Forte Biosciences's SIR currently stands at 0.27. In other words for every 100,000 Forte Biosciences shares traded daily on the market, roughly 270 shares are currently held short.

However Forte Biosciences's short interest can also be evaluated against the total number of Forte Biosciences shares, or, against the total number of tradable Forte Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Forte Biosciences's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Forte Biosciences shares in existence, roughly 100 shares are currently held short) or 0.1145% of the tradable shares (for every 100,000 tradable Forte Biosciences shares, roughly 115 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Forte Biosciences.

Find out more about how you can short Forte Biosciences stock.

Forte Biosciences share dividends

We're not expecting Forte Biosciences to pay a dividend over the next 12 months.

Have Forte Biosciences's shares ever split?

Forte Biosciences's shares were split on a 1:15 basis on 15 June 2020. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Forte Biosciences shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Forte Biosciences shares which in turn could have impacted Forte Biosciences's share price.

Forte Biosciences overview

Forte Biosciences Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing a live biotherapeutic FB-401 that has completed Phase 1/2a clinical trial to treat inflammatory skin diseases for pediatric atopic dermatitis patients. The company was incorporated in 2007 and is based in Torrance, California. .

Frequently asked questions

What percentage of Forte Biosciences is owned by insiders or institutions?
Currently 10.241% of Forte Biosciences shares are held by insiders and 53.376% by institutions. How many people work for Forte Biosciences?
Latest data suggests 10 work at Forte Biosciences. When does the fiscal year end for Forte Biosciences?
Forte Biosciences's fiscal year ends in December. Where is Forte Biosciences based?
Forte Biosciences's address is: 1124 West Carson Street, Torrance, CA, United States, 90502 What is Forte Biosciences's ISIN number?
Forte Biosciences's international securities identification number is: US34962G1094